Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study

TitleMethicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study
Publication TypeJournal Article
Year of Publication2005
AuthorsSchneider CR, Buell JF, Gearhart M, Thomas M, Hanaway MJ, Rudich SM, Woodle ES
JournalTransplant Proc
Volume37
Issue2
Pagination1243 - 4
Date PublishedMar
Accession Number15848683
Keywords*Liver Transplantation, Acetamides / therapeutic use, Female, Humans, Incidence, Intensive Care Units, Length of Stay, Male, Methicillin Resistance, Oxazolidinones / therapeutic use, Postoperative Complications / epidemiology / *microbiology, Retrospective Studies, Staphylococcal Infections / drug therapy / *epidemiology / mortality, Survival Analysis, Vancomycin / therapeutic use
Abstract

The purpose of this study was to evaluate the clinical impact of methicillin-resistant Staphylococcus aureus (MRSA) infections on transplant recipients. METHODS: Liver and kidney recipients with MRSA infections were retrospectively identified and compared to an age, gender, UNOS status, organ transplanted, and transplant date matched (2:1) non-MRSA-infected recipient control group. All MRSA infections were initially treated with vancomycin, and four (33%) liver recipients were converted to linezolid therapy after failing to improve with vancomycin. RESULTS: The overall MRSA infection incidence was 1.4% (24/1770) with MRSA more common in liver (3.75%; 12/320) than kidney transplants (0.8%; 12/1450) (P

Notify Library Reference ID1368

Related Incidents